Isogenica is a small internationally operating Biotech business that operates a range of discovery platforms supported by state of the art methodologies for identifying antibody and peptide ligands. Our platforms benefit from a combination of intelligent library design and precision library construction, to create synthetic libraries with unprecedented functional diversity.
Our platforms benefit from a combination of intelligent library design and precision library construction, to create synthetic libraries with unprecedented functional diversity.
Isogenica was originally launched to develop and operate its proprietary cell-free, DNA-based display technology, CIS display, as a platform for the discovery of polypeptide biologics.
Following the acquisition and development of further technologies, including the Colibra™ DNA library building platform, we now offer opportunities for discovery partnerships with access to our skills and tools, including next-generation, best-in-class antibody libraries such as our camelid VHH (llamdA™), Fab fragment and human scFv (Xab™) libraries.
These libraries are available for license and screening partnerships which, together with our expertise in the screening of displayed peptide and scaffold libraries, can facilitate your biologics discovery needs.